Table 2 Correlation between BRAF mutations and number of metastasis among patients with stage IV melanoma
From: Clinical significance of BRAF mutations in metastatic melanoma
Sites of Metastasis | BRAF Status | P value | |
|---|---|---|---|
| Â | Mutation N = 27 (%) | Wild Type N = 24 (%) | Â |
Soft Tissue/Lymph Nodes/Lung only | 8 (30%) | 12 (50%) | 0.16 |
Non-soft tissue site | 19 (70%) | 12 (50%) | 0.14 |
           Liver | 11 (41%) | 3 (13%) | 0.02 |